Oleg E Akilov

24PUBLICATIONS
75CO-AUTHORS
Molecular targetsMedical mycologyAllergyPredictive and prognostic markersDental materials and equipment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 25, 2026
Phase 1 Trial with Soquelitinib, a Selective ITK Inhibitor for Treatment of Relapsed/Refractory T Cell Lymphomas.

|Jun 25, 2026
IL4Rα blockade inhibits proliferation of malignant lymphocytes and the immunosuppressive tumor microenvironment of mycosis fungoides.

|Aug 22, 2025
Dermatopathological Challenges in Objectively Characterizing Immunotherapy Response in Mycosis Fungoides.

Amy Xiao, Arivarasan Karunamurthy, Oleg Akilov

|Jul 15, 2025
A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification.

Julia J Scarisbrick, Pietro Quaglino, Sean Whittaker

|Dec 19, 2024
Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma.

Francine M Foss, Youn H Kim, H Miles Prince

|Mar 15, 2024
Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon.

Tony T Jiang, Oleg Kruglov, Oleg E Akilov

Pageof 4

Frequent Collaborators

4 joint publications

Youn H Kim

3 joint publications

Marie Beylot-Barry

3 joint publications

H Miles Prince

3 joint publications

Julia J Scarisbrick